158 related articles for article (PubMed ID: 10332056)
1. Controlled release of a model protein from enzymatically degrading dextran microspheres.
Franssen O; Stenekes RJ; Hennink WE
J Control Release; 1999 May; 59(2):219-28. PubMed ID: 10332056
[TBL] [Abstract][Full Text] [Related]
2. Degradable dextran hydrogels: controlled release of a model protein from cylinders and microspheres.
Franssen O; Vandervennet L; Roders P; Hennink WE
J Control Release; 1999 Aug; 60(2-3):211-21. PubMed ID: 10425327
[TBL] [Abstract][Full Text] [Related]
3. Novel glycidyl methacrylated dextran (Dex-GMA)/gelatin hydrogel scaffolds containing microspheres loaded with bone morphogenetic proteins: formulation and characteristics.
Chen FM; Zhao YM; Sun HH; Jin T; Wang QT; Zhou W; Wu ZF; Jin Y
J Control Release; 2007 Mar; 118(1):65-77. PubMed ID: 17250921
[TBL] [Abstract][Full Text] [Related]
4. On the release of proteins from degrading dextran methacrylate hydrogels and the correlation with the rheologic properties of the hydrogels.
Meyvis T; De Smedt S; Stubbe B; Hennink W; Demeester J
Pharm Res; 2001 Nov; 18(11):1593-9. PubMed ID: 11758768
[TBL] [Abstract][Full Text] [Related]
5. Release of model proteins and basic fibroblast growth factor from in situ forming degradable dextran hydrogels.
Hiemstra C; Zhong Z; van Steenbergen MJ; Hennink WE; Feijen J
J Control Release; 2007 Sep; 122(1):71-8. PubMed ID: 17658651
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyethyl starch-based polymers for the controlled release of biomacromolecules from hydrogel microspheres.
Wöhl-Bruhn S; Bertz A; Harling S; Menzel H; Bunjes H
Eur J Pharm Biopharm; 2012 Aug; 81(3):573-81. PubMed ID: 22579731
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of periodontal tissue regeneration by locally controlled delivery of insulin-like growth factor-I from dextran-co-gelatin microspheres.
Chen FM; Zhao YM; Wu H; Deng ZH; Wang QT; Zhou W; Liu Q; Dong GY; Li K; Wu ZF; Jin Y
J Control Release; 2006 Aug; 114(2):209-22. PubMed ID: 16859799
[TBL] [Abstract][Full Text] [Related]
8. Release of bioactive BMP from dextran-derived microspheres: a novel delivery concept.
Chen FM; Wu ZF; Sun HH; Wu H; Xin SN; Wang QT; Dong GY; Ma ZW; Huang S; Zhang YJ; Jin Y
Int J Pharm; 2006 Jan; 307(1):23-32. PubMed ID: 16260104
[TBL] [Abstract][Full Text] [Related]
9. Release of recombinant human interleukin-2 from dextran-based hydrogels.
Cadée JA; de Groot CJ; Jiskoot W; den Otter W; Hennink WE
J Control Release; 2002 Jan; 78(1-3):1-13. PubMed ID: 11772444
[TBL] [Abstract][Full Text] [Related]
10. The preparation of dextran microspheres in an all-aqueous system: effect of the formulation parameters on particle characteristics.
Stenekes RJ; Franssen O; van Bommel EM; Crommelin DJ; Hennink WE
Pharm Res; 1998 Apr; 15(4):557-61. PubMed ID: 9587951
[TBL] [Abstract][Full Text] [Related]
11. A comparative biocompatibility study of microspheres based on crosslinked dextran or poly(lactic-co-glycolic)acid after subcutaneous injection in rats.
Cadée JA; Brouwer LA; den Otter W; Hennink WE; van Luyn MJ
J Biomed Mater Res; 2001 Sep; 56(4):600-9. PubMed ID: 11400139
[TBL] [Abstract][Full Text] [Related]
12. DNA-crosslinked alginate and layered microspheres to modulate the release of encapsulated FITC-dextran.
Turner D; Baldwin E; Russell K; Wells LA
Eur J Pharm Biopharm; 2021 Jan; 158():313-322. PubMed ID: 33259898
[TBL] [Abstract][Full Text] [Related]
13. [Preparation of cationic dextran microspheres loaded with tetanus toxoid and study on the mechanism of protein loading].
Zheng CL; Liu XQ; Zhu JB; Zhao YN
Yao Xue Xue Bao; 2010 Sep; 45(9):1183-7. PubMed ID: 21351577
[TBL] [Abstract][Full Text] [Related]
14. Development of Recombinant Human Growth Hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase/aqueous phase emulsion method.
Kang J; Wu F; Cai Y; Xu M; He M; Yuan W
Eur J Pharm Sci; 2014 Oct; 62():141-7. PubMed ID: 24907681
[TBL] [Abstract][Full Text] [Related]
15. Effect of excipients on the encapsulation efficiency and release of human growth hormone from dextran microspheres.
Vlugt-Wensink KD; Meijer YJ; van Steenbergen MJ; Verrijk R; Jiskoot W; Crommelin DJ; Hennink WE
Eur J Pharm Biopharm; 2007 Nov; 67(3):589-96. PubMed ID: 17540550
[TBL] [Abstract][Full Text] [Related]
16. Modeling the release of proteins from degrading crosslinked dextran microspheres using kinetic Monte Carlo simulations.
Vlugt-Wensink KD; Vlugt TJ; Jiskoot W; Crommelin DJ; Verrijk R; Hennink WE
J Control Release; 2006 Mar; 111(1-2):117-27. PubMed ID: 16430986
[TBL] [Abstract][Full Text] [Related]
17. Rapidly in situ-forming degradable hydrogels from dextran thiols through Michael addition.
Hiemstra C; Aa LJ; Zhong Z; Dijkstra PJ; Feijen J
Biomacromolecules; 2007 May; 8(5):1548-56. PubMed ID: 17425366
[TBL] [Abstract][Full Text] [Related]
18. Double-stimuli-responsive degradation of hydrogels consisting of oligopeptide-terminated poly(ethylene glycol) and dextran with an interpenetrating polymer network.
Kurisawa M; Terano M; Yui N
J Biomater Sci Polym Ed; 1997; 8(9):691-708. PubMed ID: 9257182
[TBL] [Abstract][Full Text] [Related]
19. Albumin release from biodegradable hydrogels composed of dextran and poly(ethylene glycol) macromer.
Kim IS; Jeong YI; Kim DH; Lee YH; Kim SH
Arch Pharm Res; 2001 Feb; 24(1):69-73. PubMed ID: 11235815
[TBL] [Abstract][Full Text] [Related]
20. Macroporous interconnected dextran scaffolds of controlled porosity for tissue-engineering applications.
Lévesque SG; Lim RM; Shoichet MS
Biomaterials; 2005 Dec; 26(35):7436-46. PubMed ID: 16023718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
